Last updated on June 2019

Systemic Corticosteroids Avoidance Study in Severe Asthma Patients

Brief description of study

The overall purpose of this study is to determine the efficacy of fevipiprant (dose 1 and dose 2 once daily), compared with placebo, as add-on to standard-of-care asthma therapy, in terms of avoidance of coricosteroid use over 52 weeks.

Clinical Study Identifier: NCT03629249

Find a site near you

Start Over

Novartis Investigative Site

Waldorf, MD United States
  Connect »